The Molecular Basis Of Resistance To The Antiproliferative Effect Of Egfr Inhibition In Human Glioblastoma Multiforme Cell Lines
Download and Read The Molecular Basis Of Resistance To The Antiproliferative Effect Of Egfr Inhibition In Human Glioblastoma Multiforme Cell Lines full books in PDF, ePUB, and Kindle. Read online free The Molecular Basis Of Resistance To The Antiproliferative Effect Of Egfr Inhibition In Human Glioblastoma Multiforme Cell Lines ebook anywhere anytime directly on your device. We cannot guarantee that every ebooks is available!
The Molecular Basis of Resistance to the Antiproliferative Effect of EGFR Inhibition in Human Glioblastoma Multiforme Cell Lines
Author | : Georg Karpel-Massler |
Publisher | : |
Total Pages | : |
Release | : 2011 |
Genre | : |
ISBN | : 9789533075884 |
Download The Molecular Basis of Resistance to the Antiproliferative Effect of EGFR Inhibition in Human Glioblastoma Multiforme Cell Lines Book in PDF, Epub and Kindle
The Molecular Basis of Resistance to the Antiproliferative Effect of EGFR Inhibition in Human Glioblastoma Multiforme Cell Lines Related Books
Language: en
Pages:
Pages:
Type: BOOK - Published: 2011 - Publisher:
Language: en
Pages: 832
Pages: 832
Type: BOOK - Published: 2021-06-25 - Publisher: Academic Press
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies brings current knowledge from an international team of experts
Language: en
Pages: 65
Pages: 65
Type: BOOK - Published: 2012 - Publisher:
Glioblastoma is the most common and most aggressive form of malignant primary brain tumor in adults. The epidermal growth factor receptor (EGFR) is a compelling
Language: en
Pages: 436
Pages: 436
Type: BOOK - Published: 2011-03-23 - Publisher: Springer Science & Business Media
The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine
Language: en
Pages:
Pages:
Type: BOOK - Published: 2019 - Publisher:
"Glioblastoma (GBM) is one of the most frequent, invasive and devastating primary brain tumors with a median overall survival rate of about 15 months despite ag